Roggwil, April 2, 2023 – On March 31, 2023, an exclusive sales partnership was signed with one of the largest medical technology distributors in China. This market with 1.4 billion inhabitants is probably the most interesting sales market worldwide, since 37 million new infections were counted there every day due to the lifted COVID restrictions. Around 15% of all those who have recovered from COVID have tinnitus afterwards and therefore 210 million new tinnitus patients are expected there.
++ Contact for questions:
Resaphene Suisse AG
Mrs. Anke Rauterkus (Chief Executive Officer)
T. +41 714500668